Joanna Staniszewski
Adult Health · Schaumburg, ILNPI 1457921173
Payments from drug & device makers
Across 89 payments — averaging $24.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lilly USA, LLC$399
- Tandem Diabetes Care, Inc.$376
- Antares Pharma, Inc.$163
- Currax Pharmaceuticals LLC$131
- Dexcom, Inc.$126
- AstraZeneca$100
- plus $862 from 18 others
What the payments were for
- Food & beverage$2,157100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lilly USA, LLC | 10 | $399 |
| Tandem Diabetes Care, Inc. | 8 | $376 |
| Antares Pharma, Inc. | 16 | $163 |
| Currax Pharmaceuticals LLC | 9 | $131 |
| Dexcom, Inc. | 3 | $126 |
| AstraZeneca(2 entities) | 5 | $100 |
| Boehringer Ingelheim | 5 | $99 |
| Insulet Corporation | 4 | $96 |
| Novo Nordisk | 4 | $78 |
| Amneal Pharmaceuticals LLC | 3 | $70 |
| Amgen | 4 | $64 |
| Mannkind Corporation | 3 | $61 |
| Bayer | 2 | $56 |
| Medtronic | 1 | $54 |
| Sanofi-aventis U.S. LLC | 2 | $52 |
| Corcept Therapeutics | 2 | $52 |
| Ascensia Diabetes Care US Inc. | 1 | $31 |
| Radius Health, Inc. | 1 | $27 |
| Zealand Pharma US, Inc. | 1 | $27 |
| Xeris Pharmaceuticals, Inc. | 1 | $25 |
| AbbVie | 1 | $23 |
| BETA Bionics, Inc. | 1 | $23 |
| Theracosbio, LLC | 1 | $12 |
| Vivus LLC | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,157 in reported general payments places this provider in the 85th percentile of 553 adult health providers in Illinois.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 176 | $307,235 |
| JardianceEmpagliflozin | 88 | $122,293 |
| MounjaroTirzepatide | 65 | $100,928 |
| Soliqua 100-33Insulin Glargine/Lixisenatide | 74 | $98,352 |
| FarxigaDapagliflozin Propanediol | 86 | $87,186 |
| TrulicityDulaglutide | 42 | $75,965 |
| Tresiba Flextouch U-100Insulin Degludec | 55 | $42,457 |
| Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog | 20 | $36,670 |
| Toujeo SolostarInsulin Glargine,hum.Rec.Anlog | 34 | $29,272 |
| Fiasp FlextouchInsulin Aspart (Niacinamide) | 20 | $27,634 |
| JanuviaSitagliptin Phosphate | 21 | $26,335 |
| Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog | 39 | $21,114 |
| Omnipod 5 Dexg7g6 Pods (Gen 5)Insulin Pump Cart,auto,bt,g6/7 | 19 | $18,308 |
| Nano 2nd Gen Pen NeedlePen Needle, Diabetic | 125 | $17,490 |
| RybelsusSemaglutide | 12 | $16,561 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic, Rybelsus | $78 | $323,796188 claims |
| Lilly USA, LLCMounjaro, Trulicity | $399 | $176,893107 claims |
| Boehringer IngelheimJardiance | $99 | $122,29388 claims |
| Sanofi-aventis U.S. LLCSoliqua 100-33 | $52 | $98,35274 claims |
| AstraZenecaFarxiga | $100 | $87,18686 claims |
| Amneal Pharmaceuticals LLCLevothyroxine Sodium, Unithroid | $70 | $4,280276 claims |
| AbbVieSynthroid | $23 | $3,84136 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 553 adult health providers in Illinois.
Other adult health in Schaumburg
- Jason MaslanaSchaumburg$4K
- Kimberly KearnsHoffman Estates$531K
- Leslie ForresterArlington Heights$97K
- Colleen FolkersChicago$86K
- Matthew BurkeChicago$44K
- Jacklyn GideonChicago$38K
- Jennifer GreenfieldChicago$35K
- Tammy PomaChicago$32K
- Tammy BrownNorth Chicago$31K
- Eileen SchedelAurora$21K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.